AVDL
Price
$15.76
Change
+$0.77 (+5.14%)
Updated
Sep 5 closing price
Capitalization
1.53B
59 days until earnings call
RDY
Price
$14.34
Change
+$0.19 (+1.34%)
Updated
Sep 5 closing price
Capitalization
11.97B
47 days until earnings call
Interact to see
Advertisement

AVDL vs RDY

Header iconAVDL vs RDY Comparison
Open Charts AVDL vs RDYBanner chart's image
Avadel Pharmaceuticals
Price$15.76
Change+$0.77 (+5.14%)
Volume$2.02M
Capitalization1.53B
Dr. Reddy's Laboratories
Price$14.34
Change+$0.19 (+1.34%)
Volume$678.04K
Capitalization11.97B
AVDL vs RDY Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AVDL vs. RDY commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a StrongBuy and RDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (AVDL: $15.76 vs. RDY: $14.34)
Brand notoriety: AVDL: Notable vs. RDY: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVDL: 163% vs. RDY: 54%
Market capitalization -- AVDL: $1.53B vs. RDY: $11.97B
AVDL [@Pharmaceuticals: Generic] is valued at $1.53B. RDY’s [@Pharmaceuticals: Generic] market capitalization is $11.97B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileRDY’s FA Score has 0 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • RDY’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than RDY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 4 TA indicator(s) are bullish while RDY’s TA Score has 5 bullish TA indicator(s).

  • AVDL’s TA Score: 4 bullish, 4 bearish.
  • RDY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RDY is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а +6.78% price change this week, while RDY (@Pharmaceuticals: Generic) price change was +0.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

AVDL is expected to report earnings on Nov 05, 2025.

RDY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDY($12B) has a higher market cap than AVDL($1.53B). AVDL YTD gains are higher at: 49.952 vs. RDY (-8.615). RDY has higher annual earnings (EBITDA): 98.1B vs. AVDL (7.87M). RDY has more cash in the bank: 66.7B vs. AVDL (81.5M). AVDL has less debt than RDY: AVDL (2.73M) vs RDY (48.6B). RDY has higher revenues than AVDL: RDY (334B) vs AVDL (221M).
AVDLRDYAVDL / RDY
Capitalization1.53B12B13%
EBITDA7.87M98.1B0%
Gain YTD49.952-8.615-580%
P/E RatioN/A18.54-
Revenue221M334B0%
Total Cash81.5M66.7B0%
Total Debt2.73M48.6B0%
FUNDAMENTALS RATINGS
AVDL vs RDY: Fundamental Ratings
AVDL
RDY
OUTLOOK RATING
1..100
4669
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
6155
SMR RATING
1..100
9352
PRICE GROWTH RATING
1..100
3659
P/E GROWTH RATING
1..100
4661
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDY's Valuation (78) in the Pharmaceuticals Generic industry is in the same range as AVDL (82) in the Medical Specialties industry. This means that RDY’s stock grew similarly to AVDL’s over the last 12 months.

RDY's Profit vs Risk Rating (55) in the Pharmaceuticals Generic industry is in the same range as AVDL (61) in the Medical Specialties industry. This means that RDY’s stock grew similarly to AVDL’s over the last 12 months.

RDY's SMR Rating (52) in the Pharmaceuticals Generic industry is somewhat better than the same rating for AVDL (93) in the Medical Specialties industry. This means that RDY’s stock grew somewhat faster than AVDL’s over the last 12 months.

AVDL's Price Growth Rating (36) in the Medical Specialties industry is in the same range as RDY (59) in the Pharmaceuticals Generic industry. This means that AVDL’s stock grew similarly to RDY’s over the last 12 months.

AVDL's P/E Growth Rating (46) in the Medical Specialties industry is in the same range as RDY (61) in the Pharmaceuticals Generic industry. This means that AVDL’s stock grew similarly to RDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLRDY
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 16 days ago
50%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
49%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NEWZ28.66-0.02
-0.06%
EA Series Trust StockSnips AI-Powered Sentiment US All Cap ETF
DWAW41.92-0.16
-0.37%
AdvisorShares DW FSM All Cap World ETF
ETG20.78-0.13
-0.62%
Eaton Vance Tax-Advantaged Global Dividend Income Fund
RSPF77.38-1.23
-1.56%
Invesco S&P 500® Equal Weight Fincl ETF
BERZ4.62-0.10
-2.12%
MicroSectors™ St FANG&Inn 3X Inv Ld ETNs

AVDL and

Correlation & Price change

A.I.dvisor tells us that AVDL and RMTI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVDL and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+5.14%
RMTI - AVDL
33%
Poorly correlated
-3.57%
ELAN - AVDL
30%
Poorly correlated
+5.50%
HLN - AVDL
28%
Poorly correlated
-0.41%
EBS - AVDL
28%
Poorly correlated
-0.66%
HROW - AVDL
27%
Poorly correlated
+2.18%
More

RDY and

Correlation & Price change

A.I.dvisor tells us that RDY and HROW have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.34%
HROW - RDY
30%
Poorly correlated
+2.18%
COLL - RDY
29%
Poorly correlated
-2.32%
VTRS - RDY
28%
Poorly correlated
+1.65%
AVDL - RDY
26%
Poorly correlated
+5.14%
AMPH - RDY
25%
Poorly correlated
+0.79%
More